Australia
Sigenergy Becomes Australia's Top Battery Brand by Market Share, SunWiz Reports
SYDNEY, April 28, 2025 /PRNewswire/ -- Sigenergy, a leading energy innovator, was ranked the No. 1 battery manufacturer inAustralia by blended capacity[1] for the month ofMarch 2025, according to the latest report from SunWiz, an independent expert solar consultancy. Based on kilowatt-hours (kWh)...
2025-04-28 12:27
2475
FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous EEG Monitor Approved in US
* The Australian-developed Minder system is an implantable device for continuous monitoring of brain activity in patients with epilepsy, developed to address the shortcomings in current electroencephalogram technologies * The FDA has granted authorisation for Minder under its De Novo pathway...
2025-04-23 06:15
2043
Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano
Highlights * Clarity has signed a commercial-scale agreement with Nusano, Inc. ("Nusano") for supply of copper-64 (Cu-64 or64Cu) isotope. * The 190,000 square foot Nusano facility in West Valley City, Utah is capable of producing more than 1,000 Ci (37,000 GBq) of copper-64 per day at capaci...
2025-04-17 21:01
3132
SECuRE trial update: First patient treated in the Phase II Cohort Expansion
HIGHLIGHTS * The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of the SECuRE trial has been treated with their first dose of 8 GBq of67Cu-SAR-bisPSMA.This follows the recent recommendation by the Safety Review Committee (SRC) after the successful completion of t...
2025-04-15 21:02
2598
CUBE LAUNCHES REGPLATFORM™ INTEL TO TRANSFORM THE MID-MARKET REGULATORY INTELLIGENCE LANDSCAPE IN FINANCIAL SERVICES
CUBE's new product combines the best of CUBE into a simple solution for a growing market LONDON, April 9, 2025 /PRNewswire/ -- CUBE, a global leader in Automated Regulatory Intelligence (ARI) and Regulatory Change Management (RCM), has announced the launch of RegPlatform™ Intel, its latest purpo...
2025-04-09 14:00
2194
Hydrexia and Pure Hydrogen Sign Commercial Agreement in Australia
SYDNEY and SHANGHAI, April 7, 2025 /PRNewswire/ -- Hydrexia Pty Ltd, a wholly-owned subsidiary of Hydrexia Holding Limited ("Hydrexia"), aleading hydrogen technology solution provider, and Pure Hydrogen ("PH") a leading hydrogen ecosystem developer inAustralia today announced that the two compani...
2025-04-07 21:00
3068
Bonnell Electric Unleashes the 775 Series: The Future of Electric Performance is Here
AUSTIN, Texas, April 1, 2025 /PRNewswire/ -- Bonnell Electric is shaking up the e-MTB and e-moto landscape with the official launch of the 775 series. A revolutionary blend of power, precision, and adaptability, the 775 lineup is designed to push boundaries, offering three distinct ways to ride—w...
2025-04-01 23:30
3671
Seeing Machines Announces 3D Camera Technology for Next-Generation In-Cabin Monitoring Systems
* Seeing Machines and Airy3D partner to supply the Automotive industry with low-impact, trustworthy 3D-vision for future in-cabin systems. CANBERRA, Australia, April 1, 2025 /PRNewswire/ -- Seeing Machines, the advanced computer vision technology company that designs AI-powered operator monitor...
2025-04-01 22:20
2742
Canadian Solar and Flow Power to Install Innovative Anti-Hail Solar Panels
Canadian Solar's new anti-hail technology is set to be installed at a new South
Australian solar BESS energy project by Flow Power, enhancing the resilience of
solar energy inAustralia's harsh climate.
KITCHENER, ON, April 1, 2025 /PRNewswire/ -- Canadian Solar Inc.
2025-04-01 19:00
2722
ECHO IQ SIGNS STRATEGIC PARTNERSHIP AND INTEGRATION AGREEMENTS WITH SCIMAGE AND MEDAXIOM TO EXPAND ECHOSOLV AS ACROSS 36 US CARDIOLOGY NETWORKS
* EchoSolv AS will be fully integrated into ScImage's medical workflow platform, facilitating streamlined deployment within MedAxiom's hospital and cardiology networks. * ScImage is a nationally recognised Cloud and integrated workflow management platform, with over 1,200 users, specialisin...
2025-04-01 13:39
2708
NEURIM PHARMACEUTICALS RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR PEDIATRIC PROLONGED-RELEASE MELATONIN (SLENYTO®) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
TEL AVIV, Israel, March 26, 2025 /PRNewswire/ -- Neurim Pharmaceuticals
2025-03-26 17:00
3270
Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I NMIBC Trial, Data Presented at EAU 2025
NANTONG, China and MELBOURNE, Australia, March 24, 2025 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage biopharmaceutical company pioneering small activating RNA (saRNA) therapeutics, today announced the presentation of positive preliminary data from its ongoing Phase I clinical trial of ...
2025-03-24 20:30
2777
Seeing Machines announces new technology and safety appointments
CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Seeing Machines Limited (AIM: SEE, "Seeing Machines" or the "Company"), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, is pleased to announce the appointment ofJoh...
2025-03-24 15:00
2167
GCF Global Research Amplifies Movie-Goers' Voices: They Want More
Nothing Stands in the Way of a Cinema Visit When the Right Movie is Playing SYDNEY, March 19, 2025 /PRNewswire/ -- The Global Cinema Federation (GCF), representing global cinema exhibition, is excited to announce the results of its latest global customer research, highlighting the voices of consu...
2025-03-20 02:00
2085
CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL
* Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming to reshape the standard-of-care landscape. * CS5001 is also being investigated globally in a multi-center Phase Ib clinical trial for multiple solid tumor...
2025-03-06 08:10
2445
SECuRE trial update: 92% of pre-chemo participants experience greater than 35% drop in PSA levels across all cohorts. Cohort Expansion Phase commences.
HIGHLIGHTS * Safety Review Committee (SRC) meeting confirms end of the Dose Escalation Phase and commencement of the Cohort Expansion Phase (Phase II stage) of the SECuRE study. * Based on the efficacy and safety assessment of all cohorts and the focus on earlier stages of treatment, the SRC...
2025-03-05 21:44
2800
Seeing Machines names Mitsubishi Electric Automotive America as a referral partner to drive accelerated sales of Guardian Generation 3 in The Americas
CANBERRA, Australia, Feb. 24, 2025 /PRNewswire/ -- Seeing Machines Limited (AIM: SEE), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport safety, announces that Mitsubishi Electric Automotive America, Inc. ("MEAA") has signed a...
2025-02-24 20:00
2799
FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA
* YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1 * First-in-class novel PTH replacement therapy * Australia becomes the first country to obtain Marketing Authorisation for YORVIPATH s...
2025-02-21 00:01
2863
Silicon Quantum Computing achieves world-leading accuracy of Grover's algorithm without error correction
SYDNEY, Feb. 20, 2025 /PRNewswire/ -- Silicon Quantum Computing (SQC), a pioneer in quantum computing and atomic manufacturing, today announced that it has demonstrated world-leading accuracy in the operation of Grover's algorithm without error correction, i.e. in its native pure form. This prove...
2025-02-20 18:10
2521
Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA
SYDNEY, Feb. 19, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce thatthe Un...
2025-02-19 22:09
2899
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 322 media titles]
2026-02-24 12:00
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 290 media titles]
2026-02-24 16:13
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 288 media titles]
2026-02-23 10:09